KR20140139073A - 항암제 - Google Patents

항암제 Download PDF

Info

Publication number
KR20140139073A
KR20140139073A KR1020147029903A KR20147029903A KR20140139073A KR 20140139073 A KR20140139073 A KR 20140139073A KR 1020147029903 A KR1020147029903 A KR 1020147029903A KR 20147029903 A KR20147029903 A KR 20147029903A KR 20140139073 A KR20140139073 A KR 20140139073A
Authority
KR
South Korea
Prior art keywords
extract
actin
actinin
anticancer agent
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147029903A
Other languages
English (en)
Korean (ko)
Inventor
히로야수 에스미
마사후미 이케다
치카 미요시
시게토시 카도타
토시키 오쿠보
사토시 요모다
타카후미 퓨즈
타카노리 가와시마
시게키 치바
Original Assignee
구라시에제약 주식회사
내셔날 유니버시티 코포레이션 유니버시티 오브 토야마
도쿠리츠교세이호진 고쿠리츠간켄큐센터
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 구라시에제약 주식회사, 내셔날 유니버시티 코포레이션 유니버시티 오브 토야마, 도쿠리츠교세이호진 고쿠리츠간켄큐센터 filed Critical 구라시에제약 주식회사
Publication of KR20140139073A publication Critical patent/KR20140139073A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020147029903A 2012-03-26 2013-03-26 항암제 Ceased KR20140139073A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2012-069964 2012-03-26
JP2012069964 2012-03-26
PCT/JP2013/058692 WO2013146734A1 (ja) 2012-03-26 2013-03-26 抗癌剤

Publications (1)

Publication Number Publication Date
KR20140139073A true KR20140139073A (ko) 2014-12-04

Family

ID=49259985

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147029903A Ceased KR20140139073A (ko) 2012-03-26 2013-03-26 항암제

Country Status (8)

Country Link
US (1) US9700572B2 (enExample)
EP (1) EP2832355A4 (enExample)
JP (1) JP5707534B2 (enExample)
KR (1) KR20140139073A (enExample)
CN (1) CN104379143A (enExample)
HK (1) HK1203811A1 (enExample)
IN (1) IN2014MN01973A (enExample)
WO (1) WO2013146734A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5696191B2 (ja) * 2013-04-27 2015-04-08 クラシエ製薬株式会社 抗癌幹細胞剤
JP2016079163A (ja) * 2014-10-14 2016-05-16 医療環境テクノ株式会社 腫瘍を処置するための組成物およびその製造方法
JP6773665B2 (ja) * 2015-10-09 2020-10-21 クラシエ製薬株式会社 血管壁強化剤、血管壁を強化する方法および血管網形成抑制剤
JP6876502B2 (ja) * 2016-04-25 2021-05-26 クラシエホールディングス株式会社 未分化細胞除去剤
CN105832719B (zh) * 2016-04-28 2019-05-03 上海中医药大学附属龙华医院 牛蒡苷元在调节pp2a活性中的应用
CN109045010B (zh) * 2018-09-19 2021-03-30 淮海工学院 一种具有抗肿瘤作用的药物组合物及其应用
US11412028B2 (en) 2019-02-08 2022-08-09 Bluepipes, Inc. Online platform and a method for facilitating sharing of data between users
JP7526562B2 (ja) * 2019-11-21 2024-08-01 クラシエ株式会社 レンギョウ葉の加工方法および加工レンギョウ葉

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002065298A (ja) 2000-08-30 2002-03-05 Japan Science & Technology Corp 薬剤成分のスクリーニング方法
CN101036644A (zh) * 2006-03-13 2007-09-19 海南盛科天然药物研究院有限公司 含牛蒡子苷元的药用组合物及其制备方法
KR20080107794A (ko) * 2007-06-08 2008-12-11 경남대학교 산학협력단 우방자 추출물을 함유하는 항암 조성물
EP2412377B1 (en) * 2009-03-27 2018-12-26 Kracie Holdings Ltd. Burdock fruit extract containing arctigenin at high content and process for producing same
KR101538450B1 (ko) 2010-09-27 2015-07-22 구라시에제약 주식회사 악티게닌 함유 우방자 추출물 및 그 제조방법
CN102440986B (zh) * 2010-10-08 2014-12-03 鲁南制药集团股份有限公司 牛蒡子苷元在制备防治辐射或化学品引起的骨髓抑制的药物中的用途

Also Published As

Publication number Publication date
HK1203811A1 (en) 2015-11-06
IN2014MN01973A (enExample) 2015-07-10
WO2013146734A1 (ja) 2013-10-03
US20150196576A1 (en) 2015-07-16
JPWO2013146734A1 (ja) 2015-12-14
US9700572B2 (en) 2017-07-11
JP5707534B2 (ja) 2015-04-30
EP2832355A1 (en) 2015-02-04
CN104379143A (zh) 2015-02-25
EP2832355A4 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
KR20140139073A (ko) 항암제
RU2662953C1 (ru) Способ получения экстрактов из рода panax, включая дикий женьшень или женьшень, либо камбиальных меристематических клеток, происходящих из рода panax, или их экстрактов, содержащих редкие гинсенозиды в большом количестве
KR101538450B1 (ko) 악티게닌 함유 우방자 추출물 및 그 제조방법
CN105769891B (zh) 低极性稀有人参皂苷混合物及其用途
KR20160094861A (ko) 알데히드 억제제 및 비구아나이드 계열 화합물을 포함하는 암 줄기세포의 성장 억제용 약학적 조성물
CN104758277A (zh) 绿原酸在制备治疗癌症的多药耐药性的药物中的用途
JP6389958B2 (ja) 瓦草５環性トリテルペンサポニン類化合物抗腫瘍の薬物用途
JP5696191B2 (ja) 抗癌幹細胞剤
JP6234553B2 (ja) 抗癌剤および副作用軽減剤
CN101474383A (zh) 大蒜总皂苷的制备方法及其产品和应用
KR20210039297A (ko) 마 유래 세포외 소포체 및 이의 용도
CN118459621A (zh) 中药多糖在抗呼吸道病毒感染中的应用
TWI542347B (zh) The use of arctigenin for the preparation of anticancer agents
CN106309758B (zh) 一种抗胃肠癌的药物组合物
CN102858359A (zh) 一种含有醇溶性且非水溶性甘草提取物的药物组合物,及其药物制剂、制药用途、治疗方法和制备方法
CN102961384A (zh) 紫丹参甲素的医药用途
CN102477039B (zh) 瓜馥木内酰胺碱化合物的制备方法及其在制备抗肿瘤药物中的应用
JP2016079163A (ja) 腫瘍を処置するための組成物およびその製造方法
CN110151824A (zh) 一种治疗下咽癌的药物组合物及其制备方法
JP5441023B2 (ja) 腫瘍を処置するための組成物およびその製造方法
KR20180135845A (ko) 황칠나무 유래 나노입자를 포함하는 암 예방 또는 치료용 약학적 조성물
JP6886188B2 (ja) 白血病細胞増殖抑制用組成物
CN107982265A (zh) 一种用于治疗肺癌的组合物
KR20040036092A (ko) 진세노사이드 Rh2 및 Rg3 항암 조성물
KR20180116904A (ko) 황칠나무 유래 나노입자를 포함하는 암 예방 또는 치료용 약학적 조성물

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20141024

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180201

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190102

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190314

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20190102

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I